These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9457102)

  • 21. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
    Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
    Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism.
    Delva P; Degan M; Capra C; Fallo F; Mantero F; Menegazzi M; Lechi C; Steele A; Lechi A
    Miner Electrolyte Metab; 1989; 15(5):315-20. PubMed ID: 2554104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary sodium and central vs. peripheral ouabain-like activity in Dahl salt-sensitive vs. salt-resistant rats.
    Leenen FH; Harmsen E; Yu H
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1916-20. PubMed ID: 7977822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states.
    Gonick HC; Ding Y; Vaziri ND; Bagrov AY; Fedorova OV
    Clin Exp Hypertens; 1998; 20(5-6):617-27. PubMed ID: 9682918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Involvement of ouabain (digitalis-like factor) in the pathogenesis of hypertension and hypertensive target-organ damage].
    Goto A; Yamada K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():169-73. PubMed ID: 15171364
    [No Abstract]   [Full Text] [Related]  

  • 27. Digitalis-like substance discovered in human plasma.
    Brady SR
    Hawaii Med J; 1989 Mar; 48(3):97. PubMed ID: 2543651
    [No Abstract]   [Full Text] [Related]  

  • 28. Vasoactive role of endogenous digoxin-like factor in rats with experimental hypertension.
    Pohlová I; Kunes J; Stolba P; Jelínek J; Zicha J
    Cor Vasa; 1986; 28(4):298-305. PubMed ID: 3021389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension.
    Ferrandi M; Manunta P; Rivera R; Bianchi G; Ferrari P
    Clin Exp Hypertens; 1998; 20(5-6):629-39. PubMed ID: 9682919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digoxin-like immunoreactivity may contribute to hyperinsulinemia-associated hypertension in patients with glucose intolerance.
    Takahashi H; Matsusawa M; Nishimura M; Nakanishi T; Yoshimura M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S22-4. PubMed ID: 7508019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy.
    Mahon N; Mckenna WJ
    Eur Heart J; 2000 Jul; 21(13):1034-6. PubMed ID: 10843817
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes and simulated weightlessness in rats.
    Pamnani MB; Chen S; Haddy FJ; Yuan C; Mo Z
    Clin Exp Hypertens; 1998; 20(5-6):509-21. PubMed ID: 9682907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive mechanism of exercise.
    Arakawa K
    J Hypertens; 1993 Mar; 11(3):223-9. PubMed ID: 8387079
    [No Abstract]   [Full Text] [Related]  

  • 35. Ouabain-like natriuretic factor and atrial natriuretic factor in pregnancy.
    Fievet P; Gregoire I; Fournier A; Roth D; Siegenthaler G; el Esper N; Favre H; De Bold A
    Kidney Int Suppl; 1988 Sep; 25():S89-92. PubMed ID: 2846941
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of hypertension.
    Haddy FJ
    N Engl J Med; 2007 Aug; 357(8):827-9; author reply 827-9. PubMed ID: 17715419
    [No Abstract]   [Full Text] [Related]  

  • 37. Physiology and pharmacology of endogenous digitalis-like factors.
    Goto A; Yamada K; Yagi N; Yoshioka M; Sugimoto T
    Pharmacol Rev; 1992 Sep; 44(3):377-99. PubMed ID: 1332083
    [No Abstract]   [Full Text] [Related]  

  • 38. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
    Balzan S; Montali U; Biver P; Ghione S
    J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
    De Mendonca M; Grichois ML; Pernollet MG; Thorman B; Meyer P; Devynck MA; Garay R
    J Hypertens Suppl; 1985 Dec; 3(3):S73-5. PubMed ID: 2856827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.